Recent developments in PD-1/PD-L1 blockade research for gastroesophageal malignancies
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1043517
Abstract: Gastroesophageal cancers (GECs) comprise malignancies in the stomach, esophagus, and gastroesophageal junction. Despite ongoing improvements in chemoradiotherapy, the clinical outcomes of GEC have not significantly improved over the years, and treatment remains challenging. Immune checkpoint… read more here.
Keywords: blockade research; clinical trials; developments blockade; gastroesophageal ... See more keywords